SEC Form 4 · accession 0001127602-18-000583
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert J Bertolini
Director
Period of report
Jan 2, 2018
Accepted (ET)
Jan 3, 2018 · 4:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 2, 2018 | M | 7,740 | $40.27 | A | 30,326 | D | |
| Common Stock | Jan 2, 2018 | S | 100 | $109.12 | D | 30,226 | D | |
| Common Stock | Jan 2, 2018 | S | 200 | $109.18 | D | 30,026 | D | |
| Common Stock | Jan 2, 2018 | S | 100 | $109.20 | D | 29,926 | D | |
| Common Stock | Jan 2, 2018 | S | 300 | $109.24 | D | 29,626 | D | |
| Common Stock | Jan 2, 2018 | S | 100 | $109.345 | D | 29,526 | D | |
| Common Stock | Jan 2, 2018 | S | 5 | $109.445 | D | 29,521 | D | |
| Common Stock | Jan 2, 2018 | S | 200 | $109.45 | D | 29,321 | D | |
| Common Stock | Jan 2, 2018 | S | 100 | $109.46 | D | 29,221 | D | |
| Common Stock | Jan 2, 2018 | S | 100 | $109.465 | D | 29,121 | D | |
| Common Stock | Jan 2, 2018 | S | 200 | $109.52 | D | 28,921 | D | |
| Common Stock | Jan 2, 2018 | S | 114 | $109.555 | D | 28,807 | D | |
| Common Stock | Jan 2, 2018 | S | 90 | $109.59 | D | 28,717 | D | |
| Common Stock | Jan 2, 2018 | S | 10 | $109.595 | D | 28,707 | D | |
| Common Stock | Jan 2, 2018 | S | 300 | $109.61 | D | 28,407 | D | |
| Common Stock | Jan 2, 2018 | S | 100 | $109.66 | D | 28,307 | D | |
| Common Stock | Jan 2, 2018 | S | 100 | $109.68 | D | 28,207 | D | |
| Common Stock | Jan 2, 2018 | S | 200 | $109.695 | D | 28,007 | D | |
| Common Stock | Jan 2, 2018 | S | 200 | $109.70 | D | 27,807 | D | |
| Common Stock | Jan 2, 2018 | S | 500 | $109.73 | D | 27,307 | D | |
| Common Stock | Jan 2, 2018 | S | 100 | $109.735 | D | 27,207 | D | |
| Common Stock | Jan 2, 2018 | S | 100 | $109.74 | D | 27,107 | D | |
| Common Stock | Jan 2, 2018 | S | 100 | $109.745 | D | 27,007 | D | |
| Common Stock | Jan 2, 2018 | S | 190 | $109.755 | D | 26,817 | D | |
| Common Stock | Jan 2, 2018 | S | 200 | $109.79 | D | 26,617 | D | |
| Common Stock | Jan 2, 2018 | S | 100 | $109.805 | D | 26,517 | D | |
| Common Stock | Jan 2, 2018 | S | 10 | $109.82 | D | 26,507 | D | |
| Common Stock | Jan 2, 2018 | S | 212 | $109.83 | D | 26,295 | D | |
| Common Stock | Jan 2, 2018 | S | 100 | $110.035 | D | 26,195 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $40.27 | Jan 2, 2018 | M | 7,740 | D | May 11, 2012 | May 11, 2018 | Common Stock | 7,740 | 0 | D |
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.